Physician profile
Orrin Pail
NPI 1922533447
$991.57
in general payments reported to CMS, 2019-2025
8 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $72.07 · 2023: $134 · 2024: $334 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.58 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $264.93 | 2021-2023 | |
| Kite Pharma, INC. | $203.85 | 2024 | Yescarta |
| Abbvie INC. | $148.87 | 2025 | |
| Sobi, INC | $123.70 | 2025 | |
| Pfizer INC. | $99.99 | 2024 | |
| Genzyme Corporation | $72.07 | 2022 | |
| Blueprint Medicines Corporation | $64.51 | 2023-2024 | Ayvakit |
| Daiichi Sankyo INC. | $13.65 | 2025 | Vanflyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orrin Pail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.